1. Home
  2. MRNA vs MFC Comparison

MRNA vs MFC Comparison

Compare MRNA & MFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Moderna Inc.

MRNA

Moderna Inc.

N/A

Current Price

$199.18

Market Cap

91.2B

Sector

Health Care

ML Signal

N/A

Logo Manulife Financial Corporation

MFC

Manulife Financial Corporation

N/A

Current Price

$42.22

Market Cap

73.2B

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
MRNA
MFC
Founded
2010
1887
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Life Insurance
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
91.2B
73.2B
IPO Year
2018
2002

Fundamental Metrics

Financial Performance
Metric
MRNA
MFC
Price
$199.18
$42.22
Analyst Decision
Hold
Analyst Count
23
0
Target Price
★ $164.53
N/A
AVG Volume (30 Days)
★ 11.4M
1.2M
Earning Date
11-06-2026
11-04-2026
Dividend Yield
N/A
★ 3.26%
EPS Growth
★ 21.77
N/A
EPS
N/A
★ N/A
Revenue
★ $19,263,000,000.00
N/A
Revenue This Year
$24.09
$91.93
Revenue Next Year
$11.33
N/A
P/E Ratio
★ N/A
$16.52
Revenue Growth
★ 4.29
N/A
52 Week Low
$22.28
$32.66
52 Week High
$280.80
$46.19

Technical Indicators

Market Signals
Indicator
MRNA
MFC
Relative Strength Index (RSI) 43.06 37.24
Support Level $181.02 $41.62
Resistance Level $254.48 $45.06
Average True Range (ATR) 17.92 0.78
MACD -7.14 -0.25
Stochastic Oscillator 11.39 3.61

Price Performance

Historical Comparison
MRNA
MFC

About MRNA Moderna Inc.

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 25 mRNA development candidates in clinical studies as of March 2026. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.

About MFC Manulife Financial Corporation

Manulife Financial is one of the Big Three Canadian life insurers. The firm provides life insurance, annuities, asset management, and wealth management products to individuals and group customers in Canada, the United States, and Asia. The Canadian business segment contributes approximately 21% of 2025 adjusted earnings. The Asia segment operates across 12 countries and contributes around 38% of earnings, with a significant presence in Hong Kong and Singapore. The US business, which primarily operates under the John Hancock brand, contributes about 16% of earnings. Manulife's global asset and wealth management business contributes approximately 25% of its earnings. The firm had around CAD 1.2 trillion in assets under management and administration as of the end of June 2026.

Share on Social Networks: